Twinstrand Biosciences
Latest round
- Series B
Last raised
- Apr 2021
Total raised
- $66M
Investors
- 7
About Twinstrand Biosciences
Founded in 2015 and headquartered in Seattle, US, Twinstrand Biosciences specializes in genomic sequencing technologies.Twinstrand Biosciences specializes in advanced genomic sequencing technologies, primarily focusing on its flagship product, TwinStrand Duplex Sequencing®. This technology enhances sequencing accuracy by reducing error rates from 1-in-100 to 1-in-10 million. It independently tracks both strands of DNA molecules, allowing researchers to detect low-frequency variants often undetectable by standard next-generation sequencing (NGS) methods.Twinstrand Biosciences generates revenue through the sale of its Duplex Sequencing technology and associated research kits, which are marketed for research use only. Transactions mainly occur via direct sales to research institutions and collaborations with pharmaceutical companies seeking tailored genomic research solutions. Their pricing structure reflects the advanced capabilities of their technologies, and clients often engage in multi-year agreements or one-time purchases of research kits tailored to their specifications. The company aims to develop new products designed for emerging genomic applications while exploring opportunities for expansion into new markets, particularly in Europe and Asia, by the end of 2023.
Who invested in Twinstrand Biosciences
7 investors across 2 rounds
See all investors in Twinstrand Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Twinstrand Biosciences
Who invested in Twinstrand Biosciences?
Twinstrand Biosciences has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Twinstrand Biosciences raised?
Twinstrand Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Twinstrand Biosciences last raise money?
Twinstrand Biosciences's most recent round on record is a Series B, in Apr 2021.
What does Twinstrand Biosciences do?
Founded in 2015 and headquartered in Seattle, US, Twinstrand Biosciences specializes in genomic sequencing technologies.
Where is Twinstrand Biosciences headquartered?
Twinstrand Biosciences is headquartered in Seattle, US.
Which VCs invest in companies like Twinstrand Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Twinstrand Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Twinstrand Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.